Efficacy of Prophylactic Glycerin Suppositories for Feeding Intolerance in Very Low Birth Weight Preterm Infants: a Randomized Trial
Primary Purpose
Infant, Very Low Birth Weight
Status
Recruiting
Phase
Not Applicable
Locations
Saudi Arabia
Study Type
Interventional
Intervention
Glycerin suppositories
Sponsored by
About this trial
This is an interventional prevention trial for Infant, Very Low Birth Weight focused on measuring Glycerin suppositories, Feeding intolerance, preterm infants, prophylactic use, elimination of meconium
Eligibility Criteria
Inclusion Criteria:
- Preterm infants with birth weight < 1250g.
- Inborn or outborn infants
- Less than 72 hours of age.
Exclusion Criteria:
- Congenital malformations.
- Acute abdomen needing surgical intervention.
- Severity of illness such that death is likely in the first few days after birth.
- Inability to get the parental consent.
Sites / Locations
- King Faisal Specialist Hospital & Research CentreRecruiting
- Security Forces Hospital
- Sulaiman Al habib Medical Center
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Intervention
Control
Arm Description
Intervention group will receive the glycerin suppository
Normal care
Outcomes
Primary Outcome Measures
days to achieve full tolerated feeding (breast milk or formula) by NGT or by mouth (140cc/kg/day)
Secondary Outcome Measures
Incidence of feeding intolerance
which is defined by the presence of GRVs > 50 % of the previous feed for two consecutive feeds in addition to two of the following: I. Abdominal distention > 1 cm in 12 hour. II. Abdominal tenderness. III. Vomiting. IV. Bile stained aspirate.
Incidence of necrotizing enterocolitis (NEC)
Full Information
NCT ID
NCT01799629
First Posted
February 25, 2013
Last Updated
March 28, 2022
Sponsor
King Faisal Specialist Hospital & Research Center
Collaborators
Dr. Sulaiman Alhabib Medical City, Riyadh, Security Forces Hospital
1. Study Identification
Unique Protocol Identification Number
NCT01799629
Brief Title
Efficacy of Prophylactic Glycerin Suppositories for Feeding Intolerance in Very Low Birth Weight Preterm Infants: a Randomized Trial
Official Title
Efficacy of Prophylactic Glycerin Suppositories for Feeding Intolerance in Very Low Birth Weight Preterm Infants: a Randomized Trial
Study Type
Interventional
2. Study Status
Record Verification Date
March 2022
Overall Recruitment Status
Recruiting
Study Start Date
March 2013 (Actual)
Primary Completion Date
December 2022 (Anticipated)
Study Completion Date
January 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
King Faisal Specialist Hospital & Research Center
Collaborators
Dr. Sulaiman Alhabib Medical City, Riyadh, Security Forces Hospital
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
To evaluate the efficacy of prophylactic glycerin suppositories will accelerate the elimination of meconium from the large intestine and thus reduce the incidence of feeding intolerance in very low birth weight (VLBW) infants
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Infant, Very Low Birth Weight
Keywords
Glycerin suppositories, Feeding intolerance, preterm infants, prophylactic use, elimination of meconium
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
220 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Intervention
Arm Type
Experimental
Arm Description
Intervention group will receive the glycerin suppository
Arm Title
Control
Arm Type
No Intervention
Arm Description
Normal care
Intervention Type
Drug
Intervention Name(s)
Glycerin suppositories
Primary Outcome Measure Information:
Title
days to achieve full tolerated feeding (breast milk or formula) by NGT or by mouth (140cc/kg/day)
Time Frame
2years
Secondary Outcome Measure Information:
Title
Incidence of feeding intolerance
Description
which is defined by the presence of GRVs > 50 % of the previous feed for two consecutive feeds in addition to two of the following: I. Abdominal distention > 1 cm in 12 hour. II. Abdominal tenderness. III. Vomiting. IV. Bile stained aspirate.
Time Frame
2years
Title
Incidence of necrotizing enterocolitis (NEC)
Time Frame
2years
10. Eligibility
Sex
All
Maximum Age & Unit of Time
1 Month
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Preterm infants with birth weight < 1250g.
Inborn or outborn infants
Less than 72 hours of age.
Exclusion Criteria:
Congenital malformations.
Acute abdomen needing surgical intervention.
Severity of illness such that death is likely in the first few days after birth.
Inability to get the parental consent.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Emad M Khadawardi, MD
Organizational Affiliation
King Faisal Specialist Hospital & Research Centre
Official's Role
Principal Investigator
Facility Information:
Facility Name
King Faisal Specialist Hospital & Research Centre
City
Riyadh
ZIP/Postal Code
11211
Country
Saudi Arabia
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Eamd m Khadawardi, MD
Phone
00966505541843
Email
ekhadawardi@kfshrc.edu.sa
First Name & Middle Initial & Last Name & Degree
Emad M Khadawardi, MD
First Name & Middle Initial & Last Name & Degree
Eyad Almidani, MD
First Name & Middle Initial & Last Name & Degree
Khalid Al-Faleh, MD
First Name & Middle Initial & Last Name & Degree
Khalid Alhussain, MD
First Name & Middle Initial & Last Name & Degree
Jasim Anabrees, MD
Facility Name
Security Forces Hospital
City
Riyadh
Country
Saudi Arabia
Individual Site Status
Completed
Facility Name
Sulaiman Al habib Medical Center
City
Riyadh
Country
Saudi Arabia
Individual Site Status
Completed
12. IPD Sharing Statement
Learn more about this trial
Efficacy of Prophylactic Glycerin Suppositories for Feeding Intolerance in Very Low Birth Weight Preterm Infants: a Randomized Trial
We'll reach out to this number within 24 hrs